Source:http://linkedlifedata.com/resource/pubmed/id/11510978
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-8-20
|
pubmed:abstractText |
This study aims to investigate whether the immunohistochemical expression of galectin-8 could be used as a diagnostic marker in tumor tissues of various histogenetic origins including specimens from epithelial (n=145), mesenchymatous (n=16), adipous (n=10) and central and peripheral nervous system (n=25) tissue, and 4 mesotheliomas. Immunohistochemical reactions were carried out with a polyclonal anti-galectin-8 antibody and histological slides from tissues derived from the files of the Laboratory of Anatomopathology of University Erasmus Hospital, Brussels. Formalin-fixed paraffin-embedded tissues of 45 normal cases as well as 41 benign and 114 malignant tumors were studied. Marked decreases in immunohistochemical galectin-8 expression were observed in colon (p=0.001), pancreas (p=0.007), liver (p=0.0008), skin (p=0.002) and larynx (p=0.02) tissue when comparing malignant tissue to normal tissue and/or benign tumors. The reverse relationship was observed for breast tissue (p=0.007). No statistically significant differences (p>0.05) were detected when comparing normal tissue and/or benign to malignant tumors in lung, bladder, kidney, prostate and stomach tissue. Significant galectin-8 expression was also measured in non-epithelial tissue including tumors of the central and peripheral nervous system as well as in skeletal muscle and mesotheliomas. Immunohistochemical monitoring of galectin-8 thus reveals an organ-type-dependent regulation of expression upon malignant transformation of various tissue types of epithelial origin. This observation will prompt further studies to delineate any relationship with prognosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0213-3911
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
861-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11510978-Adipose Tissue,
pubmed-meshheading:11510978-Breast,
pubmed-meshheading:11510978-Breast Neoplasms,
pubmed-meshheading:11510978-Case-Control Studies,
pubmed-meshheading:11510978-Epithelium,
pubmed-meshheading:11510978-Female,
pubmed-meshheading:11510978-Galectins,
pubmed-meshheading:11510978-Humans,
pubmed-meshheading:11510978-Immunohistochemistry,
pubmed-meshheading:11510978-Lectins,
pubmed-meshheading:11510978-Male,
pubmed-meshheading:11510978-Mesoderm,
pubmed-meshheading:11510978-Neoplasms, Adipose Tissue,
pubmed-meshheading:11510978-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:11510978-Nervous System,
pubmed-meshheading:11510978-Nervous System Neoplasms
|
pubmed:year |
2001
|
pubmed:articleTitle |
Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system.
|
pubmed:affiliation |
Laboratory of Histopathology, Faculty of Medicine, Université Libre de Bruxelles, Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|